In Vitro Evaluation of Eudragit Matrices for Oral Delivery of BCG Vaccine to Animals
Bacillus Calmette−Guérin (BCG) vaccine is the only licensed vaccine against tuberculosis (TB) in humans and animals. It is most commonly administered parenterally, but oral delivery is highly advantageous for the immunisation of cattle and wildlife hosts of TB in particular. Since...
Saved in:
Main Authors: | Imran Saleem (Author), Allan G. A. Coombes (Author), Mark A. Chambers (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices
by: Ehsan Kaffash, et al.
Published: (2021) -
Preparation and Evaluation of Eudragit L100-PEG Proliponiosomes for Enhanced Oral Delivery of Celecoxib
by: Min-Hwan Kim, et al.
Published: (2020) -
Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system
by: Rohit Mehta, et al.
Published: (2013) -
Bioreactor-Grown Bacillus of Calmette and Guérin (BCG) Vaccine Protects Badgers against Virulent <i>Mycobacterium bovis</i> When Administered Orally: Identifying Limitations in Baited Vaccine Delivery
by: Sandrine Lesellier, et al.
Published: (2020) -
BCG-osis after BCG vaccination in immunocompromised children: Case series and review
by: Soheila Shahmohammadi, et al.
Published: (2014)